What Causes Brown Discharge After Sex?
Postcoital brown discharge—light to dark brown vaginal bleeding or spotting that occurs after sexual intercourse—is a relatively common gynecologic concern. While often benign, it warrants clinical ev
Postcoital brown discharge—light to dark brown vaginal bleeding or spotting that occurs after sexual intercourse—is a relatively common gynecologic concern. While often benign, it warrants clinical evaluation because it can signal underlying conditions ranging from minor mucosal irritation to more serious pathology.
Brown discharge typically represents old blood that has oxidized as it passed slowly through the genital tract. Its appearance after intercourse may result from several mechanisms: microtrauma to the vaginal or cervical epithelium during penetration; cervical ectropion (also known as cervical eversion), where fragile columnar epithelium is exposed on the ectocervix and prone to contact bleeding; or cervical polyps—benign, vascular growths that bleed easily with friction.
More clinically significant causes include cervical dysplasia or early-stage cervical cancer, particularly in individuals with persistent high-risk human papillomavirus (HPV) infection. Endometrial abnormalities—such as endometrial polyps, hyperplasia, or, less commonly, endometrial carcinoma—may also manifest as postcoital spotting, especially in perimenopausal or postmenopausal individuals. Infections like chlamydia, gonorrhea, or bacterial vaginosis can induce cervical inflammation and friability, increasing susceptibility to postcoital bleeding.
Additional considerations include atrophic vaginitis in estrogen-deficient states (e.g., menopause or lactation), which leads to thinning and increased fragility of vaginal tissues, and iatrogenic causes such as recent cervical procedures (e.g., biopsy, cryotherapy, or LEEP). Rarely, coagulopathies or anticoagulant use may contribute.
Any episode of postcoital bleeding—regardless of volume, frequency, or associated symptoms—should prompt timely gynecologic assessment. Evaluation typically includes a detailed history (including menstrual pattern, contraceptive use, HPV vaccination status, and risk factors for STIs), speculum and bimanual examination, cervical cytology (Pap test), and HPV co-testing when indicated. Colposcopy with directed biopsy is recommended if cytology is abnormal or if high-risk features are observed. Transvaginal ultrasound may be used to assess endometrial thickness and morphology, particularly in symptomatic individuals over age 45 or those with risk factors for endometrial pathology.
Although many cases resolve spontaneously or with conservative management—such as topical estrogen for atrophy or antibiotic therapy for infection—persistent or recurrent postcoital brown discharge requires thorough investigation to exclude premalignant or malignant disease. Early detection remains critical for optimal outcomes, especially in cervical and endometrial cancers.